FOLH1 and prostate carcinoma: It is important to note than in this study, although high PSMA uptake was noted both on [68Ga]Ga-PSMA-11 PET CT and post-therapeutic images, retention times and tumor doses were lower and shorter than in prostate cancer, probably explaining the reduced effectiveness of the treatment compared to the VISION trial.